BDMAX | JMNSX | BDMAX / JMNSX | |
Total Expense Ratio | 1.59 | 2.46 | 65% |
Annual Report Gross Expense Ratio | 1.70 | 2.59 | 66% |
Fund Existence | 13 years | 16 years | - |
Gain YTD | 11.544 | 3.716 | 311% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.88B | 407M | 1,691% |
Annual Yield % from dividends | 9.98 | 2.41 | 414% |
Returns for 1 year | 13.98 | 3.70 | 377% |
Returns for 3 years | 60.01 | 31.33 | 192% |
Returns for 5 years | 59.16 | 22.73 | 260% |
Returns for 10 years | 53.92 | 15.11 | 357% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MINFX | 40.21 | N/A | N/A |
MFS International Intrinsic Value R2 | |||
VYRIX | 11.44 | N/A | N/A |
VY® T. Rowe Price Divers Mid Cap Gr R6 | |||
GAHPX | 29.99 | N/A | N/A |
Goldman Sachs Emerging Markets Eq P | |||
IFTAX | 12.23 | N/A | N/A |
Voya International High Div Low Vol A | |||
BIPSX | 29.47 | N/A | N/A |
ProFunds Biotechnology UltraSector Svc |